» Articles » PMID: 9578573

Human Neutrophils Employ Myeloperoxidase to Convert Alpha-amino Acids to a Battery of Reactive Aldehydes: a Pathway for Aldehyde Generation at Sites of Inflammation

Overview
Journal Biochemistry
Specialty Biochemistry
Date 1998 Jun 6
PMID 9578573
Citations 26
Authors
Affiliations
Soon will be listed here.
Abstract

We have recently demonstrated that activated phagocytes employ the heme protein myeloperoxidase, H2O2, and Cl- to oxidize the aromatic amino acid l-tyrosine to the reactive aldehyde p-hydroxyphenylacetaldehyde. We now present evidence for the generality of this reaction by demonstrating that neutrophils employ the myeloperoxidase-H2O2-Cl- system to oxidize nearly all of the common alpha-amino acids to yield a family of reactive aldehydes. Chemical characterization suggested that reactive carbonyl moieties were generated during amino acid oxidation by myeloperoxidase. The structures of amino-acid-derived aldehydes were confirmed using a variety of mass spectrometric methods. Aldehyde production required myeloperoxidase, H2O2, Cl-, and an amino acid; it was inhibited by heme poisons and catalase. Hypochlorous acid was the apparent oxidizing intermediate because its addition to alpha-amino acids resulted in the formation of the anticipated aldehyde. Stimulated human neutrophils likewise generated aldehydes from all classes of alpha-amino acids by a pathway inhibited by heme poisons and catalase, implicating myeloperoxidase and H2O2 in the cell-mediated reaction. Aldehyde production accounted for a significant fraction of the H2O2 generated by stimulated neutrophils at physiological concentrations of amino acids. Collectively, these results suggest that amino-acid-derived aldehydes represent a product of reactive oxidant species generated by activated phagocytes.

Citing Articles

Identification of Glyoxalase A in Group B and its contribution to methylglyoxal tolerance and virulence.

Akbari M, Joyce L, Spencer B, Brady A, McIver K, Doran K bioRxiv. 2024; .

PMID: 39131367 PMC: 11312555. DOI: 10.1101/2024.07.30.605887.


Myeloperoxidase inhibition protects bone marrow mononuclear cells from DNA damage induced by the TOP2 poison anti-cancer drug etoposide.

Cowell I, Austin C FEBS Open Bio. 2024; 14(6):1001-1010.

PMID: 38531625 PMC: 11148113. DOI: 10.1002/2211-5463.13799.


The aldehyde hypothesis: metabolic intermediates as antimicrobial effectors.

Darwin K, Stanley S Open Biol. 2022; 12(4):220010.

PMID: 35414258 PMC: 9006002. DOI: 10.1098/rsob.220010.


Interplay between Cellular Metabolism and the DNA Damage Response in Cancer.

Moretton A, Loizou J Cancers (Basel). 2020; 12(8).

PMID: 32722390 PMC: 7463900. DOI: 10.3390/cancers12082051.


Digging deeper into volatile organic compounds associated with cancer.

Janfaza S, Khorsand B, Nikkhah M, Zahiri J Biol Methods Protoc. 2020; 4(1):bpz014.

PMID: 32161807 PMC: 6994028. DOI: 10.1093/biomethods/bpz014.